VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma.

VIT therapy in combination with adequate local control is associated with some disease control in patients with first relapse RMS and may be another reasonable option to offer patients as salvage therapy.